Using a robotic system to improve safety and efficiency in treating early gastric cancer
Official title: Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer: a Pilot Randomized Controlled Study
Run by Shandong University · NCT06748352 · Data updated 2026-11-12
This study is testing if a new robotic system can make the treatment for early gastric cancer safer and quicker compared to the usual method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | December 30, 2024 |
| Main results expected | March 1, 2025 |
| Study ends | March 1, 2025 |
| Registry record updated | December 27, 2024 |
| Trial ID | NCT06748352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-80 with pathologically verified high-grade intraepithelial neoplasia or intramucosal carcinoma of the stomach.
✕Probably not a fit
Patients with deep submucosal invasion, lymph node metastasis, or severe underlying conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of the flexible auxiliary single-arm transluminal endoscopic robot (FASTER) system to enhance the safety and efficacy of endoscopic submucosal dissection (ESD) for early gastric cancer. Participants will be randomly assigned to receive either traditional ESD or FASTER-assisted ESD. The study aims to determine if the robotic system can reduce muscular injuries and procedure time compared to conventional methods. Patients will also keep a diary of their symptoms post-procedure to monitor outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more efficient treatment options for patients with early gastric cancer.
How similar studies have gone: While robotic-assisted procedures are gaining traction, this specific application of the FASTER system in ESD is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18-80. * Patients with pathologically verified high-grade intraepithelial neoplasia (HGIN) or intramucosal carcinoma of the stomach. Exclusion Criteria: * Patients have lesions with confirmed or potential deep submucosal invasion or lymph node metastasis. * Patients with severe underlying diseases precluding endotracheal intubation, general anesthesia, or surgery. * Patients have a history of gastric malignancy with previous radiotherapy or operative treatment leading to changes in gastric structure. * Patients have lesions with local recurrence after endoscopic resection. * Patients unable to obtain informed consent.
Where it's running
-
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Study coordinator: Xiuli Zuo Professor, MD, PhD
- Email: zuoxiuli@sdu.edu.cn
- Phone: 86+18560080066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring how dissection depth affects scar formation in early gastric cancer treatment
This study is testing how the depth of a specific surgery for early gastric cancer affects scar size and healing in patients.
-
SPADE procedure for upper stomach cancer
A multicenter study will test the SPADE operation, a special stomach reconnection technique, in patients with early upper-stomach cancer undergoing proximal gastrectomy to see if it is safe and feasible.
-
LECS with sentinel node navigation for early gastric cancer
This study tests whether combining LECS with sentinel node navigation can treat early gastric cancer while preserving stomach function in eligible patients.
-
Image-guided platform helps find sentinel lymph nodes in early gastric cancer
This study tests whether an image-guided platform with a deep learning model can find and retrieve sentinel lymph nodes better than standard palpation in people with early gastric cancer undergoing LECS-SNNS.
-
Early Gastric Cancer in China: Real-World Outcomes by Treatment Type
This project will look at real-world outcomes for about 5,000 Chinese patients with early gastric cancer treated with endoscopic resection, laparoscopic surgery, open surgery, or a combined approach to see how treatments relate to survival and recurrence.
-
H. pylori status and tissue features to predict gastric cancer behavior after endoscopic treatment
This study tests whether current H. pylori infection status and tissue features can help predict how early gastric cancer will behave after endoscopic treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.